Masimo Corp (MASI)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$168.67
Buy
$173.04
$3.84 (+2.27%)
Prices updated at 22 Nov 2024, 00:00
| Prices minimum 15 mins delay
Prices in USD
Masimo Corp is a medical technology company. The company develops, manufactures, and markets noninvasive monitoring technologies. Its product includes noninvasive blood constituent and brain and breath monitoring.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2023 | 49.00 |
| 2022 | 52.01 |
| 2021 | 65.24 |
| 2020 | 64.96 |
| 2019 | 67.09 |
| 2018 | 66.98 |
| 2017 | 66.06 |
| 2016 | 67.10 |
| 2015 | 65.07 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2024 | 4.61 |
| 2023 | 3.00 |
| 2022 | 4.75 |
| 2021 | 14.01 |
| 2020 | 14.16 |
| 2019 | 9.85 |
| 2018 | 7.11 |
| 2017 | 6.23 |
| 2016 | 5.25 |
| 2015 | 3.57 |
| 2014 | 2.63 |
Price/Forward earnings (YTD)
-
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2023 | 2.61 |
| 2022 | 5.63 |
| 2021 | 12.76 |
| 2020 | 15.46 |
| 2019 | 15.38 |
| 2018 | 18.79 |
| 2017 | 14.46 |
| 2016 | 43.75 |
| 2015 | 14.28 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2023 | 2.23 |
| 2022 | 2.40 |
| 2021 | 1.22 |
| 2020 | 1.22 |
| 2019 | 1.20 |
| 2018 | 1.19 |
| 2017 | 1.25 |
| 2016 | 1.46 |
| 2015 | 2.18 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
